Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
FDA Approves New Drug for Breast Cancer
About 20 percent of breast cancers have an increase in the amount of a protein called HER2. HER2 is a protein involved in normal cell growth. It is found in increased amounts on some types of cancer cells (HER2-positive), including some breast cancers. In t...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/Kadcyla_0.jpg?h=2f4b9444&itok=R34kYytg)
FDA Approves New Drug for Breast Cancer
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this